XTL Biopharmaceuticals Lt... (XTLB)
undefined
undefined%
At close: undefined
1.80
-1.64%
Pre-market Dec 13, 2024, 11:59 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income -1.78M -1.35M 435.00K -782.00K -1.35M 2.99M -781.00K -2.54M -4.31M -2.87M -3.71M -1.74M -1.21M -1.26M 2.59M -9.25M -24.94M -15.13M -14.02M -16.47M -14.29M
Depreciation & Amortization - 1K 1K 1K - - 1K 3.00K 7.00K 53.00K 313.00K 136.00K 94.00K 42.00K 13.00K 39.00K 108.00K 243.00K 242.00K 319.00K 440.00K
Stock-Based Compensation 3.00K 14.00K 37.00K 51.00K 5.00K 24.00K 40.00K 182.00K 148.00K 278.00K -65.00K 1.30M 73.00K - - 345.00K - 2.18M - - -
Other Working Capital 45.00K 25.00K -31.00K 23.00K -29.00K 39.00K 65.00K -5.00K 101.00K -186.00K -274.00K 80.00K - -5.00K - 570.00K - - - - -
Other Non-Cash Items 1.01M 451.00K -8.00K -33.00K 484.00K -3.82M 318.00K 1.03M 6.00K 62.00K -29.00K -75.00K -1.80M 207.00K -4.49M 333.00K 3.59M -162.00K 4.42M 72.00K 463.00K
Deferred Income Tax - - -1.46M -132.00K - - -755.00K -182.00K 2.31M 156.00K 1.48M -1.36M 1.29M - - -284.00K 48.00K -48.00K - - -
Change in Working Capital 64.00K -19.00K -54.00K 45.00K -50.00K -8.00K 52.00K -220.00K -16.00K -154.00K -483.00K 238.00K -254.00K 273.00K -597.00K -1.76M -220.00K 332.00K -1.11M 1.59M 59.00K
Operating Cash Flow -707.00K -901.00K -1.05M -850.00K -908.00K -816.00K -1.13M -1.73M -1.86M -2.47M -2.50M -1.51M -1.80M -735.00K -2.49M -10.58M -21.46M -12.59M -10.47M -14.49M -13.33M
Capital Expenditures - - - -1K -2.00K - - -66.00K -66.00K -10.00K -84.00K -86.00K -12.00K -16.00K - -2.00K -65.00K -21.00K -38.00K -180.00K -81.00K
Acquisitions - - - - - - 1K - -55.00K - - -925.00K 8.00K - - - - - -548.00K - 2.00K
Purchase of Investments - - - - - -6.30M -2.50M - -10.00K - - -170.00K -198.00K -81.00K -55.00K - - -20.84M 27.00K - -91.00K
Sales Maturities Of Investments - - - - 2.02M 7.00M - - -54.00K 1.51M 3.42M -80.00K 25.00K - - 10.60M 10.24M - 10.14M 7.96M 15.77M
Other Investing Acitivies 41.00K 36.00K 8.00K 33.00K 93.00K 74.00K 5.00K -64 75.00K 2.00K 366.00K 52.00K -8.00K -6.00K 31.00K 317.00K 458.00K 33.00K -50.00K -131.00K -112.00K
Investing Cash Flow 41.00K 36.00K 8.00K 32.00K 2.11M 778.00K -2.50M -66.00K -110.00K 1.50M 3.34M -1.21M -185.00K -103.00K -24.00K 10.91M 10.64M -20.83M 9.53M 7.65M 15.49M
Debt Repayment - - - - - - - - - - - - - - - - - - - - -
Common Stock Repurchased - - - - - - - - - - - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies - - 385.00K - - - - - 20.00K - 34.00K 1.86M 3.00K - - 210.00K - - - - -
Financial Cash Flow - - 385.00K - - - 4.89M - 3.58M 309.00K 317.00K 4.28M 1.74M 1.48M - 210.00K 8.80M 24.46M 1.51M 15.45M 4.00K
Net Cash Flow -693.00K -875.00K -662.00K -824.00K 1.20M -34.00K 1.27M -1.80M 1.66M -728.00K 1.19M 1.57M -244.00K 654.00K -2.51M 547.00K -2.02M -8.96M 572.00K 8.60M 2.17M
Free Cash Flow -707.00K -901.00K -1.05M -851.00K -910.00K -816.00K -1.13M -1.80M -1.93M -2.48M -2.58M -1.59M -1.81M -751.00K -2.49M -10.58M -21.52M -12.61M -10.50M -14.68M -13.41M